It's the richer-format variant of IHADA's flagship sensitive-skin lotion — identical quasi-drug active system as the standard Moist version, with the maltitol humectant elevated in the INCI for the enhanced hydration depth that very dry, atopic, or winter-compromised complexions need. The two-version approach (Moist for daily-driver, Very Moist for richer needs) reflects pharmaceutical-grade attention to clinical use cases rather than one-size-fits-all formulation.
The richer-format counterpart to IHADA's daily-driver Medicated Lotion Moist — identical quasi-drug active system with elevated maltitol humectant phase for very dry, atopic, or winter-compromised complexions. Same fragrance-free, alcohol-free pharmacy-grade formulation discipline as the standard variant. Strong value at pharmacy-tier pricing.
The case for it
What would change this: A concentration inside the studied range would raise this a step.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R4 decided 84 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A researched evidence row for the lead active would replace this with a verdict.
Same rule for everyone. “Good choice” is the verdict on 1,938 of 45,024 concern verdicts across the catalog; rule F2 decided 1,938 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The case for it
What would change this: A concentration inside the studied range would raise this a step.
Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R7 decided 258 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R3 decided 567 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
Also listed for Winter Skin — the actives here (Humectants, Allantoin, Licorice Root Extract, Petrolatum) are in our research queue for that concern; there is no verdict until their evidence rows are written. That is a gap in our table, not a mark against the product.
Does the jobDoes what a toner is for: not alcohol-driven, adds something real. Not measured from the label: restores skin pH, plays well with what follows.
A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide
Most pharmacy sensitive-skin lotions offer one version and call it a day. IHADA offers two — the standard Moist for normal-to-mildly-dry sensitive skin, and this Very Moist version for genuinely dry, atopic, or winter-compromised complexions that need more substantial hydration depth. The two-version approach mirrors what the other major Japanese sensitive-skin pharmacy houses do with their paired daily-driver and intensive lotions. It's the right approach for chronic sensitive-skin formulation, and it's what Shiseido Medical's pharmaceutical-grade research thinking enables.
The formulation difference between the two IHADA lotion versions is minimal but meaningful. The quasi-drug active system is identical — allantoin and dipotassium glycyrrhizate at the same regulatory-approved concentrations. The ultra-pure petrolatum component is the same. The NMF components (sodium PCA, sodium glutamate, betaine) are the same. The electrolyte balance system (calcium chloride, magnesium chloride) is the same. What changes is the maltitol position in the INCI — elevated in the Very Moist variant to deliver more sustained humectant action than the standard Moist version provides. The result is a noticeably more cushioned post-application feel without any compromise to the line's fragrance-free, alcohol-free, sensitive-skin-disciplined formulation philosophy.
Maltitol is a sugar-alcohol humectant with slower kinetics than glycerin — it binds water more durably and releases it more gradually, which means hydration delivered through a maltitol-elevated formula lasts longer on skin than the same concentration delivered through glycerin alone. The Very Moist variant leverages this maltitol-glycerin combination to deliver the workday-holding hydration that very dry skin requires.
In practical use the lotion performs as a winter-routine workhorse. Pour a generous palmful into clean dry hands, warm briefly, and pat into damp skin after cleansing. The slightly thicker watery lotion (still thin enough to absorb in 35-45 seconds — not cream-thick) leaves skin feeling noticeably more cushioned than the standard Moist version. Within 2 weeks of replacing a harsher toner with IHADA Very Moist in a winter routine, very dry complexions typically report measurably less mid-day tightness, fewer post-cleanse flare episodes, and better overall comfort through cold-weather skin stress. Layering logic matters here more than with a Western toner: the lotion sets the hydration baseline, and the matching emulsion or balm seals it — the layered system measurably outperforms either step alone on compromised skin, which is exactly how Japanese routines expect these products to be used.
The fragrance-free positioning is genuinely fragrance-free, identical to the standard Moist variant. No masking perfumes, no 'natural' aromatic extracts, no fragrance hiding under other ingredient names. The formula is also alcohol-free, paraben-free, silicone-free, and free of common contact sensitizers. For chronic atopic, eczema-prone, and post-procedure recovery users specifically choosing this lotion for the most vulnerable periods, the formulation discipline is non-negotiable. A few smaller formulation notes round out the picture. Erythritol and methyl gluceth-10 extend the humectant chain beyond the headline maltitol, giving the water-binding system three tiers of molecular size; the whole thing is fungal-acne safe and considered pregnancy-safe; and the one ingredient a very small population should note is sodium metabisulfite, a sulfite stabilizer that the rare sulfite-sensitive user will want to patch test around.
Value is identical to the standard Moist variant — about $16 for 180ml at Japanese pharmacy pricing. The per-ml cost is competitive within the Japanese pharmacy sensitive-skin segment — the major rival lines cluster in the same $13-18 band — and well below Western sensitive-skin specialist brands. The 180ml bottle lasts about 2-3 months at twice-daily face use, putting monthly cost at about $6. The choice between the Moist and Very Moist variants is a format preference rather than a value question — same price, same actives, different humectant load and texture feel. The domestic reputation backs the design: around 1,800 reviews averaging 4.5, a standing presence in @cosme's sensitive-skin lotion rankings, and frequent recommendation by Japanese dermatologists for atopic and eczema patients heading into winter — with the recurring complaints limited to the lotion-thin texture (which is the format, not a flaw) and the difficulty of buying it outside Japan.
The natural audience is very dry, atopic, eczema-prone, or compromised-barrier complexions in cold-climate winters seeking pharmaceutical-grade soothing-and-hydration support; anyone who has tried the standard IHADA Moist variant and found it too light; routine builders adding IHADA to a winter sensitive-skin rotation; post-procedure recovery users in dry seasons who need extra hydration support.
The wrong matches are just as clear. Oily complexions and humid-climate residents will find the standard Moist variant sufficient; cruelty-free purchasers are ruled out by Shiseido's mainland China distribution; anyone seeking treatment-tier actives — vitamin C, retinol, AHA/BHA — is shopping in the wrong aisle, because this is soothing-and-hydration support only; and users who want a more distinctive formulation differentiator may find a pseudoceramide-led or amino-acid-led rival line better matched to their specific skin needs.
The broader take: this is what Shiseido Medical's pharmaceutical-grade formulation thinking produces when applied to the most challenging chronic sensitive-skin use cases. The two-version approach lets users match format to skin condition rather than forcing compromise; the maltitol-elevated humectant phase delivers real chemistry-driven richness rather than just texture-building thickening. For users in the target demographic with very dry sensitive skin or chronic atopic management needs, the Very Moist variant earns its place in the IHADA routine as the format the most challenging cases reach for.
The hero actives that drive this product's performance.
| Ingredient | Function | Evidence |
|---|---|---|
| Allantoin (Quasi-Drug Active) | Same quasi-drug roughness-prevention active as the Moist variant — works in the Very Moist version's slightly richer formulation to soothe the chronic atopic and eczema-prone presentations that need extra hydration depth alongside the soothing claim. | Limited for Post-Procedure |
| Dipotassium Glycyrrhizate (Quasi-Drug Active) | The second quasi-drug active — licorice-derived anti-inflammatory paired with allantoin for the dual-active soothing system that defines IHADA's medicated positioning. | Limited for Eczema |
| Maltitol (Enhanced Humectant) | Sits higher in the INCI in the Very Moist version than in the standard Moist variant — maltitol is a longer-acting sugar-alcohol humectant that delivers more sustained hydration than glycerin alone. This is the key formulation difference that justifies the 'Very Moist' positioning. | Not yet assessed |
| Petrolatum + Multi-Humectant System | Pharmaceutical-grade ultra-pure petrolatum at low concentration provides the modest occlusive support that helps the enhanced humectant load retain water on chronically dry skin. The combination is engineered for users whose barrier compromise requires more than the standard Moist formulation provides. | Regulator-approved for Dryness · established mechanism |
| NMF Components + Electrolyte Balance | Sodium PCA, sodium glutamate, betaine deliver native NMF replenishment; calcium chloride and magnesium chloride provide electrolyte balance that supports stratum corneum osmotic homeostasis. This pharmaceutical-grade attention to barrier physiology distinguishes IHADA from cosmetic-tier sensitive-skin lotions. | Not yet assessed |
Ingredient standings describe the active at treatment-level doses and vehicles; this product's own condition grades weigh its actual formula.
Water, Glycerin, Butylene Glycol, Dipropylene Glycol, Maltitol, Methyl Gluceth-10, PEG/PPG-14/7 Dimethyl Ether, Betaine, PEG-40 Hydrogenated Castor Oil, Polyglyceryl-10 Diisostearate, Triethylhexanoin, Sodium Citrate, Erythritol, Citric Acid, Sodium Metaphosphate, Sodium Metabisulfite, Sodium Glutamate, Sodium PCA, Allantoin, Dipotassium Glycyrrhizate, Petrolatum, Calcium Chloride, Magnesium Chloride, Phenoxyethanol
toner
AM & PM
Apply after cleansing as the first leave-on step. Use generous palmful and pat in. The Very Moist version is the right pick for harsh winters, eczema flares, or any context where the standard Moist variant doesn't deliver enough hydration depth.
Immediate soothing and a noticeably more cushioned post-application feel than the Moist variant; cumulative barrier-improvement over 2-4 weeks of consistent twice-daily use.
The chemistry difference between IHADA Moist and Very Moist is the maltitol humectant elevation. Maltitol is a disaccharide sugar alcohol (4-O-alpha-D-glucopyranosyl-D-glucitol) with documented humectant activity that's slower and more sustained than glycerin's quick osmotic water draw. The published research on maltitol in cosmetic formulations supports its role as a longer-acting humectant that complements faster-acting humectants like glycerin for sustained hydration delivery.
The quasi-drug active system is identical to the Moist variant. Allantoin's documented mild keratolytic and soothing activity at the Japanese regulatory-approved concentration delivers roughness-prevention character. Dipotassium glycyrrhizate's anti-inflammatory mechanism through lipoxygenase and cyclooxygenase pathway inhibition delivers inflammation-reduction character.
The pharmaceutical-grade petrolatum at low concentration provides modest occlusive support — reducing transepidermal water loss by approximately 90% in the small percentage of formula coverage where it deposits on skin. The combination of elevated maltitol humectant and petrolatum occlusive is what gives the Very Moist variant its sustained-hydration character.
The NMF components (sodium PCA, sodium glutamate, betaine) deliver natural moisturizing factor replenishment in their native form. The electrolyte balance system (calcium chloride, magnesium chloride) supports stratum corneum osmotic homeostasis.
The full multi-humectant phase (glycerin, butylene glycol, dipropylene glycol, methyl gluceth-10, maltitol, erythritol) delivers complementary water-binding mechanisms — fast-acting glycerin for immediate plumping, slower-acting maltitol and erythritol for sustained hydration past the initial absorption window. The diversity of humectants is what enables the formula to maintain hydration through a workday rather than just delivering brief post-application moisture.
The Very Moist variant of IHADA Medicated Lotion is among the pharmacy lotions most frequently suggested by Japanese dermatologists for patients with chronic atopic dermatitis, eczema in winter conditions, severe xerosis, and post-procedure recovery contexts where the standard Moist variant doesn't provide sufficient hydration depth. The dual quasi-drug active system delivers reliable soothing-and-inflammation reduction; the elevated maltitol humectant addresses the sustained-hydration needs that compromised barriers require. Clinically the appealing characteristics are identical to the standard Moist variant — quasi-drug regulatory backing, genuine fragrance-free formulation, pharmaceutical-grade petrolatum, comprehensive NMF system — with the addition of the richer hydration profile that some patient presentations require. For patients with severe dry-sensitive skin or chronic atopic management needs in cold-climate conditions, the Very Moist variant is the right pick within the IHADA range. Recommendations typically pair it with the IHADA Emulsion for emulsion-step layering and the IHADA Balm for severe-flare occlusive support.
After cleansing, pour a generous palmful (about 2-3ml, approximately a 500-yen-coin sized amount) into clean dry hands. Warm briefly between hands. Pat into damp skin without rubbing or wiping. Avoid cotton-pad application. Allow about 30-45 seconds for absorption before applying the next layer. Follow with IHADA Medicated Emulsion for brand-consistent layering, plus IHADA Balm for very dry winter conditions. Safe for use morning and evening; daily consistency supports the cumulative barrier-tolerance benefit.
At approximately $16 for 180ml at Japanese pharmacy pricing, this is identically priced with the standard Moist variant — Shiseido Medical doesn't charge a premium for the richer version, which is appropriate since the formulation cost difference is small (elevated maltitol concentration, no additional active ingredients). The per-ml cost is competitive within the Japanese pharmacy sensitive-skin segment and well below Western sensitive-skin specialist brands. The 180ml bottle lasts about 2-3 months of twice-daily face use, putting monthly cost at about $6. The choice between Moist and Very Moist is a format preference rather than a value calculation — same money, same actives, different texture feel and humectant duration. Strong overall value for the pharmaceutical-grade formulation depth.
Very dry, atopic, eczema-prone, or compromised-barrier complexions in cold-climate winters seeking pharmaceutical-grade soothing-and-hydration support. Anyone who has tried the standard IHADA Moist variant and found it too light. Routine builders adding IHADA to a winter sensitive-skin rotation. Post-procedure recovery users in dry seasons.
Oily complexions or those in humid climates (the standard Moist variant is sufficient). Cruelty-free purchasers ruled out by Shiseido's mainland China distribution. Users seeking treatment-tier actives rather than soothing-and-hydration support. Users who prefer Curel's pseudoceramide focus or Minon's amino-acid focus — IHADA's allantoin-and-licorice approach is meaningfully different.
Ready to try IHADA Medicated Lotion Very Moist?
Buy at Amazon ♥Slightly thicker watery lotion than the Moist variant; pours readily and absorbs in 35-45 seconds with a noticeably more cushioned feel.
Genuinely fragrance-free — only the faint inherent ingredient note typical of a clean pharmacy formulation.
Standard plastic bottle with flip-top cap; functional pharmacy design.
First use is noticeably more cushioned than the standard Moist version — the elevated maltitol humectant gives a more substantive post-application feel without making the lotion heavy or sticky. Within 2 weeks, very dry and atopic-prone complexions typically report measurably less mid-day tightness and better cumulative comfort.
About 2-3 months applied morning and night face use from the 180ml bottle.
fall winter
IHADA launched in 2014 as Shiseido Medical's sensitive-skin brand. The Very Moist variant was added to give chronic atopic and very dry-skin users an option richer than the standard Moist version without sacrificing the line's fragrance-free formulation discipline. The two-version approach mirrors what Minon (Lotion I vs Lotion II) and Curel do with their lotion ranges — letting users match format to skin condition rather than settling for compromise.
IHADA is Shiseido Medical's dedicated sensitive-skin pharmacy brand, launched in 2014 specifically for chronic atopic and barrier-compromised complexions. Positioned in Japanese drugstores' medicated skincare section with quasi-drug regulatory status for its active ingredients — backed by Shiseido's pharmaceutical division research rather than the cosmetic division.
A 'Very Moist' pharmacy lotion is just a thickener-loaded version of the standard formula.
In some brands, yes. IHADA's Very Moist adds meaningful maltitol humectant load — a real chemistry difference, not just a thickener gimmick. The richer feel comes from sustained-hydration chemistry rather than just texture-building polymers.
Sensitive-skin lotions become less effective when paired with rich moisturizers on top.
They become more effective. The lotion's job is to set up hydration baseline; the moisturizer's job is to seal that hydration with occlusive support. The layered approach delivers measurably better barrier results than either step alone in compromised-barrier conditions.
Pick Very Moist if your skin is genuinely dry, if you live in a cold-winter climate, or if you've tried the Moist variant and found it too light. Pick Moist if your skin is normal-to-mildly-dry sensitive or if you're in a humid climate. Many users keep both and switch seasonally — winter Very Moist, summer Moist.
Maltitol position in the INCI. The Very Moist variant elevates maltitol higher in the ingredient list, which delivers meaningfully more sustained humectant action. The quasi-drug actives (allantoin, dipotassium glycyrrhizate) are identical between the two versions, as is the petrolatum component and the NMF supporting cast.
Mostly no. The Very Moist lotion delivers richer hydration than the standard Moist version, but it's still a lotion-format toner and not a moisturizer. For winter routines on dry skin, follow with the IHADA Emulsion and (for severe cases) the IHADA Balm to complete the barrier-supportive layering.
Yes — it's one of the lotions Japanese dermatologists frequently suggest specifically for atopic flares and post-flare recovery, when the standard Moist formulation isn't providing enough hydration support. Works alongside (not instead of) any prescribed topical treatments.
Yes — genuinely fragrance-free, identical to the standard Moist variant. No masking perfumes, no botanical aromatic extracts, no fragrance hiding under other ingredient names.
Yes — designed for twice-daily use. The richer humectant phase doesn't increase irritation risk; it just delivers more sustained hydration than the standard Moist version.
No. Shiseido Medical distributes through mainland China retail channels where animal testing is required by local regulation, so the IHADA brand cannot claim cruelty-free certification.
Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.
Genuinely fragrance-free
Richer cushioned feel than the standard Moist variant
Quasi-drug allantoin and licorice actives soothe reactive complexions
Strong value at pharmacy-tier pricing
Pairs well with IHADA Emulsion and Balm
Texture still feels lotion-thin rather than cream-thick
Some users prefer Curel pseudoceramide focus over IHADA allantoin focus
Limited availability outside Japan
Verified answers from our questions library — the nuance a product page cannot carry.
